Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4212280
Max Phase: Preclinical
Molecular Formula: C42H65N7O6S
Molecular Weight: 796.09
Molecule Type: Small molecule
Associated Items:
ID: ALA4212280
Max Phase: Preclinical
Molecular Formula: C42H65N7O6S
Molecular Weight: 796.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N(C)[C@H](C(=O)N(C)Cc1nccs1)C(C)C)C(C)C
Standard InChI: InChI=1S/C42H65N7O6S/c1-12-17-35(50)47(10)37(29(6)7)42(55)49-22-16-20-32(49)40(53)46(9)33(25-30-18-14-13-15-19-30)38(51)44-31(24-27(2)3)39(52)48(11)36(28(4)5)41(54)45(8)26-34-43-21-23-56-34/h13-15,18-19,21,23,27-29,31-33,36-37H,12,16-17,20,22,24-26H2,1-11H3,(H,44,51)/t31-,32-,33-,36-,37-/m0/s1
Standard InChI Key: XNASEKUWNLNRSN-LMUGUXCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 796.09 | Molecular Weight (Monoisotopic): 795.4717 | AlogP: 4.46 | #Rotatable Bonds: 19 |
Polar Surface Area: 143.54 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.24 | CX Basic pKa: 2.19 | CX LogP: 3.97 | CX LogD: 3.97 |
Aromatic Rings: 2 | Heavy Atoms: 56 | QED Weighted: 0.22 | Np Likeness Score: -0.45 |
1. Iwasaki A, Tadenuma T, Sumimoto S, Ohshiro T, Ozaki K, Kobayashi K, Teruya T, Tomoda H, Suenaga K.. (2017) Biseokeaniamides A, B, and C, Sterol O-Acyltransferase Inhibitors from an Okeania sp. Marine Cyanobacterium., 80 (4): [PMID:28294609] [10.1021/acs.jnatprod.7b00137] |
2. Ohno O, Terasaki T, Sano T, Hitomi Y, Miyamoto J, Matsuno K.. (2020) Inhibitory effects of biseokeaniamide A against lipopolysaccharide-induced signal transduction., 30 (11): [PMID:32173199] [10.1016/j.bmcl.2020.127069] |
Source(1):